Therefore, both direct presentation by cancer cells and indirect cross-presentation of tumor-derived NUP214 by hematopoietic antigen-presenting cells are possible as a mechanism for activation of mutated NUP214-specific CD4+ T-cells in the tumor microenvironment. The gene discussed is NUP214; the disease is cancer.